{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:08:27Z","timestamp":1789110507821,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cataract is a frequent and visually significant complication of uveitis, yet perioperative management practices vary widely and are not always guided by standardized protocols, particularly in settings such as Pakistan where uveitis is relatively common. This study aimed to describe current perioperative management practices for uveitic cataract among ophthalmologists in Pakistan, providing an observational baseline to inform future evidence-based consensus rather than prescribing clinical recommendations, and to explore variations based on clinician experience and case volume.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This descriptive cross-sectional survey included fellowship-trained ophthalmologists in Pakistan actively managing uveitic cataract. A structured, expert-validated questionnaire assessed perioperative inflammation control, intraoperative strategies, postoperative regimens, clinical decision-making, and attitudes toward national guidelines. The survey was administered electronically from December 2025 to February 2026. Responses were stratified by clinical experience and annual case volume, and statistical analysis was performed using chi-square and Fisher\u2019s exact tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-one ophthalmologists responded (51% response rate); 68.6% had\u2009\u2264\u200910 years of post-fellowship experience. A quiescent period of \u2265\u20093 months was the most common determinant of surgical timing (72.5%). Preoperatively, intensified topical corticosteroids were widely used (72.5%), and nearly half prescribed short systemic steroids (49.0%). Combined pharmacologic\u2013mechanical strategies were preferred intraoperatively (74.5%), and 80.4% routinely implanted a primary IOL when capsular support was adequate, most commonly hydrophobic acrylic (49.0%). Postoperatively, 62.7% used systemic steroids routinely in all cases, and 47.1% routinely prescribed topical NSAIDs for cystoid macular edema prophylaxis. Preoperative macular integrity on OCT was most often identified as the strongest predictor of visual gain (45.1%). Significant differences in steroid intensification and NSAID use were observed according to surgeon experience (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Overall, 84.3% supported development of national standardized guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among surveyed Pakistani ophthalmologists, significant variability exists in perioperative management of uveitic cataract surgery, influenced by surgeon experience and annual case volume. These findings offer a regional baseline; standardized national guidelines, informed by broader consensus-building, may improve consistency and outcomes in this complex patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-05328-0","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:04:12Z","timestamp":1789059852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical practice patterns in uveitic cataract surgery: a national survey"],"prefix":"10.1186","volume":"26","author":[{"given":"Maham","family":"Imran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Imran Saleem","family":"Channar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryum","family":"Khilji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijay","family":"Tamang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhadi M. A.","family":"Mahgoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammedsadeq A.","family":"Shweliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"10","key":"5328_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.9734\/jamps\/2023\/v25i10646","volume":"25","author":"HA Khaqan","year":"2023","unstructured":"Khaqan HA, Hassan L, Jabran A, et al. Incidence of Uveitis in Local Population of Lahore. J Adv Med Pharm Sci. 2023;25(10):18\u201321. https:\/\/doi.org\/10.9734\/jamps\/2023\/v25i10646.","journal-title":"J Adv Med Pharm Sci"},{"issue":"2","key":"5328_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/sjopt.sjopt_147_21","volume":"36","author":"RS Al-Essa","year":"2022","unstructured":"Al-Essa RS, Alfawaz AM. New insights into cataract surgery in patients with uveitis: A detailed review of the current literature. Saudi J Ophthalmol. 2022;36(2):133\u201341. https:\/\/doi.org\/10.4103\/sjopt.sjopt_147_21.","journal-title":"Saudi J Ophthalmol"},{"issue":"1","key":"5328_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/09273948.2019.1668430","volume":"29","author":"AF AlBloushi","year":"2021","unstructured":"AlBloushi AF, Alfawaz AM, AlZaid A, Alsalamah AK, Gikandi PW, Abu El-Asrar AM, Incidence. Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm. 2021;29(1):128\u201336. https:\/\/doi.org\/10.1080\/09273948.2019.1668430.","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"5328_CR4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","volume":"117","author":"JE Thorne","year":"2010","unstructured":"Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids. Ophthalmology. 2010;117(7):1436\u201341. https:\/\/doi.org\/10.1016\/j.ophtha.2009.12.003.","journal-title":"Ophthalmology"},{"issue":"1","key":"5328_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/ICU.0b013e32831b9b22","volume":"20","author":"RN Van Gelder","year":"2009","unstructured":"Van Gelder RN, Leveque TK. Cataract surgery in the setting of uveitis. Curr Opin Ophthalmol. 2009;20(1):42\u20135. https:\/\/doi.org\/10.1097\/ICU.0b013e32831b9b22.","journal-title":"Curr Opin Ophthalmol"},{"issue":"13","key":"5328_CR6","first-page":"5143","volume":"48","author":"ML Belair","year":"2007","unstructured":"Belair ML, Kim SJ, Thorne JE, et al. Analysis of Cystoid Macular Edema After Cataract Surgery in Patients With and Without Uveitis Using Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2007;48(13):5143\u20135143.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"5328_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ajo.2010.04.031","volume":"150","author":"AR Loh","year":"2010","unstructured":"Loh AR, Acharya NR. Incidence Rates and Risk Factors for Ocular Complications and Vision Loss in HLA-B27-Associated Uveitis. Am J Ophthalmol. 2010;150(4):534\u2013e5422. https:\/\/doi.org\/10.1016\/j.ajo.2010.04.031.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"5328_CR8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/bjophthalmol-2016-309047","volume":"101","author":"CJ Chu","year":"2017","unstructured":"Chu CJ, Dick AD, Johnston RL, Yang YC, Denniston AK. Cataract surgery in uveitis: a multicentre database study. Br J Ophthalmol. 2017;101(8):1132\u20137. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309047.","journal-title":"Br J Ophthalmol"},{"key":"5328_CR9","doi-asserted-by":"publisher","unstructured":"Jabs DA, McCluskey P, Palestine AG, Thorne JE, The Standardization Of Uveitis Nomenclature (Sun) Working Gr. The standardisation of uveitis nomenclature (SUN) project. Clin Experiment Ophthalmol. 2022;50(9):991\u20131000. https:\/\/doi.org\/10.1111\/ceo.14175","DOI":"10.1111\/ceo.14175"},{"issue":"03","key":"5328_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3414\/ME12-01-0063","volume":"52","author":"B Trusko","year":"2013","unstructured":"Trusko B, Thorne J, Jabs D, et al. The Standardization of Uveitis Nomenclature (SUN) Project: Development of a Clinical Evidence Base Utilizing Informatics Tools and Techniques. Methods Inf Med. 2013;52(03):259\u201365. https:\/\/doi.org\/10.3414\/ME12-01-0063.","journal-title":"Methods Inf Med"},{"issue":"7","key":"5328_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/09273948.2024.2439903","volume":"33","author":"U Naz","year":"2025","unstructured":"Naz U, Naz S, Rizvi F, Kamil Z. Pattern of Uveitis in a Tertiary Care Eye Hospital Setting in Pakistan: A Comprehensive Analysis. Ocul Immunol Inflamm. 2025;33(7):1108\u201312. https:\/\/doi.org\/10.1080\/09273948.2024.2439903.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"5328_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13104-019-4432-8","volume":"12","author":"MI Ghauri","year":"2019","unstructured":"Ghauri MI, Iqbal N, Riaz SU, Irfan M, Kumar A, Mukarram MS. Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan. BMC Res Notes. 2019;12(1):404. https:\/\/doi.org\/10.1186\/s13104-019-4432-8.","journal-title":"BMC Res Notes"},{"issue":"5","key":"5328_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/09273948.2011.592260","volume":"19","author":"S Sreekantam","year":"2011","unstructured":"Sreekantam S, Denniston AKO, Murray PI. Survey of Expert Practice and Perceptions of the Supporting Clinical Evidence for the Management of Uveitis-related Cataract and Cystoid Macular Oedema. Ocul Immunol Inflamm. 2011;19(5):353\u20137. https:\/\/doi.org\/10.3109\/09273948.2011.592260.","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"5328_CR14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.4103\/ijo.IJO_740_17","volume":"65","author":"NW Chan","year":"2017","unstructured":"Chan NW, Ti SE, Chee SP. Decision-making and management of uveitic cataract. Indian J Ophthalmol. 2017;65(12):1329. https:\/\/doi.org\/10.4103\/ijo.IJO_740_17.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"5328_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/ICU.0b013e328332f575","volume":"21","author":"M Jancevski","year":"2010","unstructured":"Jancevski M, Foster CS. Cataracts and uveitis. Curr Opin Ophthalmol. 2010;21(1):10\u20134. https:\/\/doi.org\/10.1097\/ICU.0b013e328332f575.","journal-title":"Curr Opin Ophthalmol"},{"key":"5328_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajo.2018.08.041","volume":"196","author":"Y Ji","year":"2018","unstructured":"Ji Y, Hu K, Li C, et al. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis. Am J Ophthalmol. 2018;196:121\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2018.08.041.","journal-title":"Am J Ophthalmol"},{"key":"5328_CR17","doi-asserted-by":"publisher","unstructured":"Mora P, Gonzales S, Ghirardini S, et al. Perioperative prophylaxis to prevent recurrence following cataract surgery in uveitic patients: a two-centre, prospective, randomized trial. Acta Ophthalmol (Copenh). 2016;94(6). https:\/\/doi.org\/10.1111\/aos.12955.","DOI":"10.1111\/aos.12955"},{"issue":"1","key":"5328_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12348-025-00554-x","volume":"15","author":"F Alhaimi","year":"2025","unstructured":"Alhaimi F, Bakhamees W. Management and outcomes of cataract surgery in uveitic eyes with chronic hypotony: a two-case series. J Ophthalmic Inflamm Infect. 2025;15(1):95. https:\/\/doi.org\/10.1186\/s12348-025-00554-x.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"5328_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5935\/0004-2749.2025-0097","volume":"89","author":"AM Feitosa","year":"2026","unstructured":"Feitosa AM, Albano MCDF, Lopes SP, et al. Different formulations of corticosteroid eye drops at different treatment times in the control of inflammation and prevention of cystoid macular edema after cataract surgery: randomized clinical trial. Arq Bras Oftalmol. 2026;89(1):1\u20139. https:\/\/doi.org\/10.5935\/0004-2749.2025-0097.","journal-title":"Arq Bras Oftalmol"},{"issue":"10","key":"5328_CR20","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3390\/medicina59101877","volume":"59","author":"G Bajraktari","year":"2023","unstructured":"Bajraktari G, Juki\u0107 T, Kalauz M, Oroz M, Radolovi\u0107 Berteti\u0107 A, Vukojevi\u0107 N. Early and Late Complications after Cataract Surgery in Patients with Uveitis. Med (Mex). 2023;59(10):1877. https:\/\/doi.org\/10.3390\/medicina59101877.","journal-title":"Med (Mex)"},{"issue":"9","key":"5328_CR21","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.4103\/ijo.IJO_428_20","volume":"68","author":"S Chatterjee","year":"2020","unstructured":"Chatterjee S, Agrawal D, Parchand S, Sahu A. Visual outcome and prognostic factors in cataract surgery in ocular tuberculosis. Indian J Ophthalmol. 2020;68(9):1894. https:\/\/doi.org\/10.4103\/ijo.IJO_428_20.","journal-title":"Indian J Ophthalmol"},{"key":"5328_CR22","doi-asserted-by":"publisher","unstructured":"Rosenbaum J, Pasadhika S. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biol Targets Ther Published online Febr 2014:67. https:\/\/doi.org\/10.2147\/BTT.S41477","DOI":"10.2147\/BTT.S41477"},{"issue":"5","key":"5328_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4274\/tjo.galenos.2025.27917","volume":"55","author":"B Yarg\u0131 \u00d6zko\u00e7ak","year":"2025","unstructured":"Yarg\u0131 \u00d6zko\u00e7ak B, Altan \u00c7. Optimizing Perioperative Management Strategies in Uveitic Cataract Surgery: A Survey of Expert Practices. Turk J Ophthalmol. 2025;55(5):249\u201355. https:\/\/doi.org\/10.4274\/tjo.galenos.2025.27917.","journal-title":"Turk J Ophthalmol"},{"issue":"4","key":"5328_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ajo.2014.06.018","volume":"158","author":"S Mehta","year":"2014","unstructured":"Mehta S, Linton MM, Kempen JH. Outcomes of Cataract Surgery in Patients With Uveitis: A Systematic Review and Meta-analysis. Am J Ophthalmol. 2014;158(4):676\u2013e6927. https:\/\/doi.org\/10.1016\/j.ajo.2014.06.018.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5328_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12348-016-0079-y","volume":"6","author":"S Phatak","year":"2016","unstructured":"Phatak S, Lowder C, Pavesio C. Controversies in intraocular lens implantation in pediatric uveitis. J Ophthalmic Inflamm Infect. 2016;6(1):12. https:\/\/doi.org\/10.1186\/s12348-016-0079-y.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"5328_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jcjo.2016.10.007","volume":"52","author":"H Chiu","year":"2017","unstructured":"Chiu H, Dang H, Cheung C, et al. Ten-year retrospective review of outcomes following phacoemulsification with intraocular lens implantation in patients with pre-existing uveitis. Can J Ophthalmol. 2017;52(2):175\u201380. https:\/\/doi.org\/10.1016\/j.jcjo.2016.10.007.","journal-title":"Can J Ophthalmol"},{"key":"5328_CR27","doi-asserted-by":"publisher","unstructured":"Leung TG, Lindsley K, Kuo IC. Types of intraocular lenses for cataract surgery in eyes with uveitis. Cochrane Eyes and Vision Group. ed Cochrane Database Syst Rev. 2014;2014(3). https:\/\/doi.org\/10.1002\/14651858.CD007284.pub2.","DOI":"10.1002\/14651858.CD007284.pub2"},{"issue":"1","key":"5328_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12886-021-02017-y","volume":"21","author":"Y Ren","year":"2021","unstructured":"Ren Y, Du S, Zheng D, Shi Y, Pan L, Yan H. Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract. BMC Ophthalmol. 2021;21(1):245. https:\/\/doi.org\/10.1186\/s12886-021-02017-y.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"5328_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jcrs.2013.11.004","volume":"40","author":"C Caglar","year":"2014","unstructured":"Caglar C. Intracameral steroids versus subconjunctival and systemic steroids: Prevention of postoperative inflammation in cataract with anterior uveitis. J Cataract Refract Surg. 2014;40(1):166. https:\/\/doi.org\/10.1016\/j.jcrs.2013.11.004.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"5328_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ophtha.2015.09.022","volume":"123","author":"HN Sen","year":"2016","unstructured":"Sen HN, Abreu FM, Louis TA, et al. Cataract Surgery Outcomes in Uveitis. Ophthalmology. 2016;123(1):183\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.022.","journal-title":"Ophthalmology"},{"key":"5328_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.yaoo.2019.04.014","volume":"4","author":"JL Chen","year":"2019","unstructured":"Chen JL, Bhat P, Lobo-Chan AM. Perioperative Management of Uveitic Cataracts. Adv Ophthalmol Optom. 2019;4:325\u201339. https:\/\/doi.org\/10.1016\/j.yaoo.2019.04.014.","journal-title":"Adv Ophthalmol Optom"},{"issue":"1","key":"5328_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/IIO.0b013e3181c5539d","volume":"50","author":"AM Lobo","year":"2010","unstructured":"Lobo AM, Papaliodis GN. Perioperative Evaluation and Management of Cataract Surgery in Uveitis Patients. Int Ophthalmol Clin. 2010;50(1):129\u201337. https:\/\/doi.org\/10.1097\/IIO.0b013e3181c5539d.","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"5328_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/ICU.0000000000000438","volume":"29","author":"MD Conway","year":"2018","unstructured":"Conway MD, Stern E, Enfield DB, Peyman GA. Management of cataract in uveitis patients. Curr Opin Ophthalmol. 2018;29(1):69\u201374. https:\/\/doi.org\/10.1097\/ICU.0000000000000438.","journal-title":"Curr Opin Ophthalmol"},{"key":"5328_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/476525","volume":"2013","author":"A Russo","year":"2013","unstructured":"Russo A, Costagliola C, Delcassi L, et al. Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema. Mediators Inflamm. 2013;2013:1\u201311. https:\/\/doi.org\/10.1155\/2013\/476525.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"5328_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/1120672118799626","volume":"29","author":"SA El Gharbawy","year":"2019","unstructured":"El Gharbawy SA, Darwish EA, Abu Eleinen KG, Osman MH. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes. Eur J Ophthalmol. 2019;29(4):453\u20137. https:\/\/doi.org\/10.1177\/1120672118799626.","journal-title":"Eur J Ophthalmol"},{"key":"5328_CR36","unstructured":"https:\/\/fyra.io. Treatment of Uveitic Cystoid Macular Edema. Retina Today. https:\/\/retinatoday.com\/articles\/2008-nov\/1108_08-php.\u00a0Accessed February 15. 2026."},{"key":"5328_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ajo.2024.06.006","volume":"267","author":"S Gangaputra","year":"2024","unstructured":"Gangaputra S, Newcomb C, Ying GS, et al. Incidence and Remission of Post-Surgical Cystoid Macular Edema Following Cataract Surgery in Eyes With Intraocular Inflammation. Am J Ophthalmol. 2024;267:182\u201391. https:\/\/doi.org\/10.1016\/j.ajo.2024.06.006.","journal-title":"Am J Ophthalmol"},{"key":"5328_CR38","unstructured":"MD JPD. Successful ocular surgery in patients with chronic uveitis | Modern Retina. February 12. 2026. https:\/\/www.modernretina.com\/view\/successful-ocular-surgery-in-patients-with-chronic-uveitis.\u00a0Accessed February 12, 2026."},{"issue":"1","key":"5328_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12348-019-0170-2","volume":"9","author":"K Neatrour","year":"2019","unstructured":"Neatrour K, McAlpine A, Owens TB, Trivedi RH, Poole Perry LJ. Evaluation of the etiology of persistent iritis after cataract surgery. J Ophthalmic Inflamm Infect. 2019;9(1):4. https:\/\/doi.org\/10.1186\/s12348-019-0170-2.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"5328_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajo.2022.08.014","volume":"244","author":"HH Al-Ani","year":"2022","unstructured":"Al-Ani HH, Sims JL, Niederer RL. Cataract Surgery in Uveitis: Risk Factors, Outcomes, and Complications. Am J Ophthalmol. 2022;244:117\u201324. https:\/\/doi.org\/10.1016\/j.ajo.2022.08.014.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"5328_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/aos.15308","volume":"101","author":"S P\u00e5lsson","year":"2023","unstructured":"P\u00e5lsson S, Pivodic A, Gr\u00f6nlund MA, et al. Cataract surgery in patients with uveitis: Data from the Swedish National Cataract Register. Acta Ophthalmol (Copenh). 2023;101(4):376\u201383. https:\/\/doi.org\/10.1111\/aos.15308.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"12","key":"5328_CR42","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1007\/s10792-023-02860-6","volume":"43","author":"K Jevnikar","year":"2023","unstructured":"Jevnikar K, Po\u010dkar S, Umek L, Rothova A, Valentincic NV. Prognostic factors of cataract surgery in patients with uveitis. Int Ophthalmol. 2023;43(12):4605\u201312. https:\/\/doi.org\/10.1007\/s10792-023-02860-6.","journal-title":"Int Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05328-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:51:01Z","timestamp":1789109461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05328-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05328-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this study, as it was an anonymous expert survey that did not involve the use of patient data. Participation was voluntary, and completion of the survey was considered as implied consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"564"}}